You are here

Article info

Article menu
Download PDFPDF
Ovarian Cancer
Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE Trial

Authors

  1. Address correspondence and reprint requests to Antonio González-Martín, MD, Medical Oncology Department, MD Anderson Cancer Center, C/Arturo Soria 270, 28033 Madrid, Spain. E-mail: agonzalezm{at}seom.org.

Citation

González-Martín A, Pautier P, Mahner S, et al
Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE Trial
International Journal of Gynecologic Cancer 2016;26:898-905.

Publication history

  • Received December 8, 2015
  • Accepted January 26, 2016
  • First published June 1, 2016.
Online issue publication 
June 01, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.